Source: International Congress 2017 – State of the art session: "Paediatric"
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jane C. Davies (London, United Kingdom). Recent developments in the management of Cystic fibrosis. International Congress 2017 – State of the art session: "Paediatric"

Member's Comments

No comment yet.

Related content which might interest you: CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019 Year: 2020 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013 Update on new treatments for cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 Practical microbiology of cystic fibrosis lung disease Source: School Course 2013 - Cystic Fibrosis Year: 2013 Cystic fibrosis microbiology, emerging pathogens and more treatment options Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children Year: 2018 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Novel therapeutics for cystic fibrosis Source: ERS Webinar 2020: Novel therapeutics for cystic fibrosis Year: 2020 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Translational immunology in genetic lung disease: advances in cystic fibrosis and Alpha-1 anti-trypsin deficiency Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease Year: 2014 Hot topics and current controversies in non-cystic fibrosis bronchiectasis Source: Breathe, 15 (4) 286; 10.1183/20734735.0261-2019 Year: 2019 Emerging pathogens in cystic fibrosis Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases Year: 2019 Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation Source: Eur Respir Rev 2015; 24: 436-444 Year: 2015